Ardent Health Partners (NYSE:ARDT) Given Overweight Rating at Stephens

Ardent Health Partners (NYSE:ARDT)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Stephens in a report released on Tuesday,Benzinga reports. They presently have a $21.00 price target on the stock. Stephens’ target price would suggest a potential upside of 39.17% from the company’s previous close.

ARDT has been the subject of a number of other research reports. Guggenheim upped their price objective on shares of Ardent Health Partners from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Friday, May 9th. Royal Bank of Canada restated an “outperform” rating and set a $21.00 price target on shares of Ardent Health Partners in a research note on Thursday, May 15th. Morgan Stanley reduced their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research report on Tuesday, January 21st. Finally, Mizuho lowered their price objective on Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 9th. Two equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Ardent Health Partners presently has an average rating of “Buy” and a consensus price target of $20.67.

Ardent Health Partners Stock Down 2.1%

ARDT stock opened at $15.09 on Tuesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company has a 50-day moving average of $13.16 and a two-hundred day moving average of $14.79. The stock has a market capitalization of $2.16 billion and a price-to-earnings ratio of 9.26. Ardent Health Partners has a 52-week low of $11.31 and a 52-week high of $20.72.

Ardent Health Partners (NYSE:ARDT) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.08. The company had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. As a group, equities research analysts anticipate that Ardent Health Partners will post 1.23 EPS for the current year.

Hedge Funds Weigh In On Ardent Health Partners

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ARDT. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Ardent Health Partners in the 4th quarter worth approximately $27,000. US Bancorp DE bought a new position in Ardent Health Partners in the 4th quarter valued at $31,000. Morse Asset Management Inc acquired a new position in Ardent Health Partners in the first quarter worth $36,000. R Squared Ltd bought a new stake in shares of Ardent Health Partners during the fourth quarter worth $37,000. Finally, New York State Common Retirement Fund bought a new stake in shares of Ardent Health Partners during the fourth quarter worth $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.